24 Jan2014

AstraZeneca diabetes drug gets green light in EU

A pill bottle with a pile of spilled red pills against a white background

Xigduo is the first drug to combine a new class of diabetes medication known as SGLT2 inhibitors with metformin, the established treatment, in a single tablet. Photo: Alamy

AstraZeneca’s diabetes franchise receives boost as new drug gets EU approval

AstraZeneca’s diabetes franchise received a boost on Wednesday when EU regulators gave the green light to its Xigduo medicine.

24 Jan2014

2 Alzheimer’s Drugs Found Ineffective in Clinical Trials

Posted in News, World

Dashing hopes, bapineuzumab and solanezumab did not improve patients’ ability to think or perform daily activities

By Dennis Thompson
HealthDay Reporter

WEDNESDAY, Jan. 22, 2014 (HealthDay News) — Two experimental drugs for Alzheimer’s disease have failed their clinical trials, proving unable to help patients with mild to moderate dementia, according to new studies.

AstraZeneca diabetes drug gets green light in EU

AstraZeneca’s diabetes franchise receives boost as new drug gets EU approval

2 Alzheimer’s Drugs Found Ineffective in Clinical Trials

Dashing hopes, bapineuzumab and solanezumab did not improve patients’ ability to think or perform daily activities

Live tweets

Contact Us

Quick Links